Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: H01CC02

Cetrotide(cetrorelix (as acetate))

Ovulation;Ovulation Induction

Marketing Authorisation Holder: Merck Europe B.V.

EMA Authorisation: 12/04/1999

INN: cetrorelix

Indication

Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques. In clinical trials, Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Cetrotide — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.